Can a common antibiotic shield kids from chemotherapy danger?
NCT ID NCT07320534
Summary
This study aims to see if giving the antibiotic levofloxacin can help prevent or delay a dangerous condition called febrile neutropenia in children with acute lymphoblastic leukemia (ALL) during their initial chemotherapy. Researchers will compare the antibiotic to a placebo (a dummy pill) in about 124 children aged 1-18 years. The main goal is to see if the antibiotic helps children stay fever-free longer and reduces serious infections during this critical treatment phase.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RSUP dr Sardjito
Sleman, DI Yogyakarta, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.